The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 26, 2021
Filed:
Feb. 01, 2013
Applicant:
Board of Regents, the University of Texas System, Austin, TX (US);
Inventors:
Juan Fueyo-Margareto, Houston, TX (US);
Candelaria Gomez-Manzano, Houston, TX (US);
W. K. Alfred Yung, Houston, TX (US);
Victor Krasnykh, Missouri City, TX (US);
Hong Jiang, Houston, TX (US);
Assignee:
Board of Regents, The University of Texas System, Austin, TX (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); C07K 14/705 (2006.01); C07K 14/47 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70596 (2013.01); A61K 39/00115 (2018.08); A61K 39/00117 (2018.08); A61K 39/001104 (2018.08); A61K 39/001106 (2018.08); A61K 39/001114 (2018.08); A61K 39/001119 (2018.08); A61K 39/001122 (2018.08); A61K 39/001149 (2018.08); A61K 39/001151 (2018.08); A61K 39/001153 (2018.08); A61K 39/001156 (2018.08); A61K 39/001164 (2018.08); A61K 39/001166 (2018.08); A61K 39/001171 (2018.08); A61K 39/001176 (2018.08); A61K 39/001182 (2018.08); A61K 39/001184 (2018.08); A61K 39/001186 (2018.08); A61K 39/001188 (2018.08); A61K 39/001191 (2018.08); A61K 39/001192 (2018.08); A61K 39/001193 (2018.08); A61K 39/001194 (2018.08); A61K 39/001195 (2018.08); C07K 14/4748 (2013.01); C12N 7/00 (2013.01); A61K 39/0011 (2013.01); A61K 2039/5256 (2013.01); C12N 2710/10034 (2013.01); C12N 2710/10343 (2013.01);
Abstract
The present invention is directed to adenoviruses for use in cancer therapy which comprise one or more heterologous nucleic acid sequences encoding a tumor antigen, whereby the adenovirus expresses the tumor antigen(s) on its surface.